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Abstract
Introduction: Ectopic thymoma is a rare neoplasm, which can be developed in various sites, with
the lung being amongst the rarest.
Case presentation: In this paper, we present the case of a woman with a slow-growing ectopic
thymoma, stemming from the visceral pleura of the upper lobe of the left lung anteriorly, extending
into the left lung and the cardiac wall, invading the fatty tissue near the pericardium, notably without
infiltrating the lung or cardiac parenchyma. The thymoma was successfully removed via
thoracotomy.
Conclusion: Ectopic thymoma is an uncommon neoplasm. To our knowledge, a case of an ectopic
thymoma stemming from the visceral pleura of the lung is extremely rare.
Introduction
Although the vast majority of thymomas are located in the
anterior mediastinum (90%), there have been many sites
of ectopic localization of thymomas described. Ectopic
thymomas have been found in the middle and the poste-
rior mediastinum, the neck, the base of the skull, the peri-
cardium, the lung parenchyma, and the pleural cavity [1-
5]; whereas in the visceral pleura are extremely uncom-
mon [6]. In this report, we present a rare case of an asymp-
tomatic female with an ectopic thymoma stemming from
the visceral pleura of the left lung.
Case presentation
In April 2007, a 40-year-old Caucasian woman admitted
into our clinic for performing an orthopaedic operation.
The chest x-ray, which is amongst the routine pro-operat-
ing exams preceding a surgery, revealed an asymptomatic
left paramediastinal mass in the left hemithorax (Figure
1a). After a chest CT scan, there was revealed a large, 5.5
cm in diameter, multilobar mass attached to the upper
lobe of the left lung, extending into the left lung, touching
the cardiac wall and invading the pericardial fatty tissue,
without infiltrating the parenchyma of neither the lung
nor the heart (Figure 1b). The CT imaging of the abdomen
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astatic disease. Subsequently, a biopsy of the tumour was
conducted, through an FNA CT-scan. The histological
results revealed a hyperplasia of the lymphoid tissue.
Following these, the patient was scheduled for surgery.
She was operated on through a posterolateral thoracot-
omy in the 5th left intercostal space. A 5 × 6 × 4.5 cm
tumour was found with a pedicle stemming from the vis-
ceral pleura of the upper lobe of the left lung anteriorly. It
was "touching" the wall of the left lung and heart, obscur-
ing the pericardia fatty tissue. There were no signs of the
tumour infiltrating the lung or any of the adjacent struc-
tures. Note that the only connection of the tumor with the
lung was its pedicle and that there was no connection of
the tumour with the mediastinum and the thymus. Con-
sequently, the pedicle was sutureligated, divided and
removed (Figure 2).
The postoperative course was uneventful and the patient
was released from the hospital on the 5th post-operative
day. The anatomopathological examination of the sample
using optical microscopy and immunohistochemical tests
confirmed the diagnosis of an ectopic thymoma (Figure
3a, 3b). The resected specimen was a solid and elastic
multi-lobulated, grey mass, with a thick fibrous capsule.
The microscopy showed nodules of varying sizes compris-
ing a mixture of polygonal, ovoid and spindle (epithelial)
cells, associated with a dense lymphoplasmacytic infil-
trate, vascular proliferation, nuclear pleomorphism,
scanty mitoses, but no tumour giant or necrotic cells.
These histopathologic findings were consistent with a type
AB according to World Health Organization Classification
System (1999) and the pathologic stage was stage I on the
classification system of Masaoka (Table 1) [1,7,8].
Discussion
The thymus gland is an anterior mediastinal structure aris-
ing embryologically from the third, and to a lesser extent,
the fourth pharyngeal pouch. A prominent organ early in
life, the thymus reaches a maximum size of 40 g during
puberty before regressing and involuting during adult-
hood, being replaced by fibro-fatty tissue [1]. Thymoma is
an uncommon neoplasm that derives from the epithelial
cells of thymus and it is the most common neoplasm of
(a) Pre-operative chest radiographyFigu e 1
(a) Pre-operative chest radiography. (b) Pre-operative CT scan.
Thymoma after removed from the anterior periviscelar pleura of the left lungFigure 2
Thymoma after removed from the anterior perivis-
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adults at their 40 s. Nevertheless, cases of ectopic thymomas
have been found in various locations, as it has already
mentioned [1-6].
Furthermore, the thymomas have many interesting clini-
cal features, such as their unique association with
myasthenia gravis or autoimmune diseases (as pancytope-
nia, hypogammaglobulinemia). Approximately 35% of
thymoma patients have myasthenia gravis, while 5%-10%
have other systemic syndromes [1,8]. Moreover, in the
case of an ectopic thymoma, the possibility of solitary
metastases from a small undetected primary tumour in
the thymus should be considered [8,9].
The majority of the patients suffering from thymoma are
asymptomatic. However, when clinical symptoms are
present, they can roughly be differentiated between local-
izing symptoms, and systemic symptoms, due to the release of
excess hormones, antibodies, and cytokines [1,8,9]. The
most common clinical symptoms are cough (60%), chest
pain (30%), fevers/chills (20%) and dyspnea (16%)
[1,8,9]. Myasthenia gravis patients are characterized by
the development of autoimmune antibodies to the acetyl-
choline receptor on postsynaptic neuromuscular junc-
tions. These antibodies could be detected with blood tests
[8].
Nevertheless, imaging is an essential part of the workup
and in conjunction with history and physical exam is
often the only investigation needed prior to treatment [1].
Following identification of a mass on chest x-ray, a CT
scan of the chest should be obtained, as it allows for the
characterization of tumors as well as an assessment of pos-
sible invasion into surrounding structures [10]. Dynamic
magnetic resonance imaging (MRI) has been examined as
a potential way to improve staging and differential diag-
nosis determination [11], and PET has been examined for
tumor detection and differentiation between invasive and
noninvasive thymoma with mixed results [12].
The thymomas can be classified according to the degree of
invasion of the tumor through the capsule into the sur-
rounding structures (Masaoka staging system - the most
widely accepted) or according to the morphology of the
epithelial cells and the lymphocyte-to-epithelial cell ratio
(WHO system) [7-9]. Surgical resection is the standard of
care for both non-invasive and invasive thymomas as it
Table 1: Masaoka staging system
Masaoka staging system [7]
STAGE I Macroscopically encapsulated with no microscopically detectable capsular invasion.
STAGE II Macroscopic invasion of mediastinal fatty tissue or mediastinal pleura or microscopic invasion into the capsule.
STAGE III Macroscopic invasion into surrounding structures
(pericardium, great vessels, lung).
STAGE IV (A) Pleural or pericardial dissemination.
(B) Lymphogenous or hematogenous metastases.
(a) A solid nest of epithelial cells surrounded by dense lymphoplasmacytic infiltratesFigure 3
(a) A solid nest of epithelial cells surrounded by dense lymphoplasmacytic infiltrates. (b) Microscopic findings of 
spindle neoplastic epithelial cells of an ectopic thymoma.Page 3 of 4
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provides the best prognosis [13]. For locally invasive or
metastatic disease, or inoperable tumors, adjunctive ther-
apy is used, which may include chemotherapy and radia-
tion treatment [1,8,9,13].
Completely resected, Masaoka stage II and III thymomas
may benefit from adjuvant radiotherapy to reduce local
recurrence rates, but without impact on survival. In pri-
mary unresectable thymomas, multimodal strategy nowa-
days includes neo-adjuvant chemotherapy, extensive
surgery, adjuvant radiotherapy, and in some cases, adju-
vant chemotherapy. The most popular chemotherapy reg-
imens combine cisplatin, adriamycin, etoposide,
cyclophophamide, or ifosfamide [14,15].
Due to thymomas rarity, the most chemotherapeutic trials
are case reports or phase II trials, while prospective rand-
omized trials are not available, so as to compare the dif-
ferent chemotherapeutic agents. Nevertheless, the most
commonly employed drug in combination chemotherapy
of thymomas is cisplatin and several studies reported
responses in excess of 50% with these combinations
[8,13-15].
Conclusion
Ectopic thymoma is an uncommon neoplasm. To our
knowledge, a case of an ectopic thymoma stemming from
the visceral pleura of the lung is extremely rare.
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